Alzheimer’s Disease: Causes and Treatment
A special issue of J (ISSN 2571-8800). This special issue belongs to the section "Biology & Life Sciences".
Deadline for manuscript submissions: 31 December 2024
Special Issue Editor
Interests: chronic pain; severe pain; plant medicines; traditional healing; California Indian healing
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
New monoclonal antibody vaccines for Alzheimer’s disease promise relief from symptoms and slowing of disease progression. These antibodies target beta amyloid with the goal of decreasing brain loads of plaques. Several of these vaccines have been tested and failed to improve symptoms, even though the load of plaques decreased. However, lecanemab is an FDA-approved vaccine that seems to improve symptoms in early Alzheimer’s disease at least for a few months. Does this prove that beta amyloid causes Alzheimer’s disease? It is clear that diet and lifestyle are important in the cause and progression of the disease. What are the mechanisms involving poor diet and lifestyle that increase the onset and progression of the disease? Several alternative medicines have been used to treat the disease. How do these medicines work? These and other questions will be addressed in this Special Issue on Alzheimer’s disease.
Prof. Dr. James David Adams
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. J is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
